PUBLISHER: TechNavio | PRODUCT CODE: 1911367
PUBLISHER: TechNavio | PRODUCT CODE: 1911367
The global smart insulin pens and pumps market is forecasted to grow by USD 2637.0 mn during 2025-2030, accelerating at a CAGR of 15.1% during the forecast period. The report on the global smart insulin pens and pumps market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in diabetes management, increasing prevalence of diabetes worldwide, growing demand for personalized and convenient diabetes management.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 14.4% |
| CAGR | 15.1% |
| Incremental Value | $2637.0 mn |
Technavio's global smart insulin pens and pumps market is segmented as below:
By Product Type
By End-User
By Distribution Channel
Geography
This study identifies the integration of AI and machine learning for predictive capabilities as one of the prime reasons driving the global smart insulin pens and pumps market growth during the next few years. Also, emphasis on user-friendly design and interoperability and expansion of remote monitoring and telemedicine integration will lead to sizable demand in the market.
The report on the global smart insulin pens and pumps market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global smart insulin pens and pumps market vendors that include Beta Bionics Inc., CeQur SA, Debiotech SA, Delfu medical device Co. Ltd., Eli Lilly and Co., Embecta Corp., Emperra GmbH, F. Hoffmann La Roche Ltd., Haselmeier GmbH, Insulet Corp., Medtronic Plc, Medtrum Technologies Inc., Novo Nordisk AS, Owen Mumford Ltd., Sanofi SA, Sequel Med Tech LLC, SOOIL Development Co. Ltd., Tandem Diabetes Care Inc., ViCentra B.V., Ypsomed Holding AG. Also, the global smart insulin pens and pumps market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.